CHAIR
(S):
SPEAKER
(S):
Samuel Abraham, PhD, Vice President, Strategic Relationships , BC Cancer Agency
Mark Lievonen, President , sanofi pasteur
Timothy Ruane, President & CEO, Tekmira Pharmaceuticals Corporation , Tekmira Pharmaceuticals Corporation
Jacques Simard, PhD, Canada Research Chair in Oncogenetics, Laval University
Description
"Canada's world-class researchers and infrastructure, supportive innovation climate and thriving biopharmaceutical
industry make it an excellent location for partnerships and growing your global oncology business. Cancer is the leading therapeutic area in Canada's drug development pipeline, representing over 35 percent of products under development. Canada offers unparalleled opportunities for innovation and collaboration. Hear from our research and business leaders active in oncology and explore what Canada has to offer."
Objective1:"Highlight cancer research excellence from Canada's leading health innovators.
Objective2:"Offer firsthand accounts of Canada's advantages from companies operating in Canada.
Objective3:Explore why Canada's great innovation environment is the place to partner and grow your business.